Pivot Pharma Retains Cannabis Compliance to File Dealer’s License Application on Behalf of Agro-Biotech Inc.
12 mars 2018 03h30 HE
|
Pivot Pharmaceuticals Inc.
VANCOUVER, British Columbia, March 12, 2018 (GLOBE NEWSWIRE) -- via NetworkWire – Pivot Pharmaceuticals Inc. (CSE:PVOT) (OTCQB:PVOTF) (FRA:NPAT) (“Pivot” or the “Company”), is pleased to announce...
Pivot Pharma Acquires Thrudermic, LLC
06 mars 2018 09h13 HE
|
Pivot Pharmaceuticals Inc.
VANCOUVER, British Columbia, March 06, 2018 (GLOBE NEWSWIRE) -- via NetworkWire – Pivot Pharmaceuticals Inc. (CSE:PVOT) (OTCQB:PVOTF) (“Pivot” or the “Company”) is pleased to announce the...
Pivot Pharma Closes C$5M Private Placement of Convertible Debentures
05 mars 2018 08h00 HE
|
Pivot Pharmaceuticals Inc.
VANCOUVER, British Columbia, March 05, 2018 (GLOBE NEWSWIRE) -- via NetworkWire – Pivot Pharmaceuticals Inc. (CSE:PVOT) (OTCQB: PVOTF) (“Pivot” or the “Company”) is pleased to announce the closing...
Pivot Pharma Completes Acquisition of California-Based ERS Holdings, LLC
27 févr. 2018 09h29 HE
|
Pivot Pharmaceuticals Inc.
VANCOUVER, British Columbia, Feb. 27, 2018 (GLOBE NEWSWIRE) --
via NetworkWire – Pivot Pharmaceuticals Inc. (CSE:PVOT) (OTCQB:PVOTF) (“Pivot” or the “Company”) is pleased to announce that...
Pivot Pharma Announces Letter of Intent for Proposed Acquisition of Agro-Biotech, a Québec-based ACMPR Licensed Producer
22 févr. 2018 17h48 HE
|
Pivot Pharmaceuticals Inc.
VANCOUVER, British Columbia, Feb. 22, 2018 (GLOBE NEWSWIRE) -- via NetworkWire – Pivot Pharmaceuticals Inc. (CSE:PVOT) (OTCQB:PVOTF) (“Pivot” or the “Company”) is pleased to announce that it has...
Pivot Provides Market Activity Update
13 févr. 2018 15h09 HE
|
Pivot Pharmaceuticals Inc.
VANCOUVER, British Columbia, Feb. 13, 2018 (GLOBE NEWSWIRE) -- via NetworkWire - Pivot Pharmaceuticals Inc. (CSE:PVOT) (OTCQB:PVOTF) (“Pivot” or the “Company”), a biopharmaceutical company engaged...
Pivot Pharmaceuticals Provides Corporate Update
12 févr. 2018 04h00 HE
|
Pivot Pharmaceuticals Inc.
VANCOUVER, British Columbia, Feb. 12, 2018 (GLOBE NEWSWIRE) -- Pivot Pharmaceuticals Inc. (CSE:PVOT) (OTCQB:PVOTF) (“Pivot” or the “Company”), a biopharmaceutical company engaged in the development...
Pivot Files Three New Provisional Patents for the Delivery of Cannabinoids
01 févr. 2018 04h00 HE
|
Pivot Pharmaceuticals Inc.
VANCOUVER, British Columbia, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Pivot Pharmaceuticals Inc. (CSE:PVOT) (OTCQB:PVOTF) (“Pivot” or the “Company”), is pleased to announce that it has filed three...
Pivot Continues To Build Technology Portfolio
17 janv. 2018 04h00 HE
|
Pivot Pharmaceuticals Inc.
VANCOUVER, British Columbia, Jan. 17, 2018 (GLOBE NEWSWIRE) -- Pivot Pharmaceuticals Inc. (CSE:PVOT) (OTCQB:PVOTF) (“Pivot” or the “Company”), and its wholly-owned medical cannabis products...
Pivot To Initiate Topical Product Development With Israel Based Research Organizations
09 janv. 2018 07h00 HE
|
Pivot Pharmaceuticals Inc.
VANCOUVER, British Columbia, Jan. 09, 2018 (GLOBE NEWSWIRE) -- via Network NewsWire -- Pivot Pharmaceuticals Inc. (CSE:PVOT) (OTCQB:PVOTF) (“Pivot” or the “Company”), and its wholly-owned medical...